Acute pancreatitis other imaging findings: Difference between revisions
Jump to navigation
Jump to search
m (Formatting) |
Iqra Qamar (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
===Role of ERCP=== | |||
{| class="wikitable" style="width:70%;" | |||
!Recommendation | |||
!Evidence Level | |||
!Strength of Recommendation | |||
|- | |||
|Patients with acute pancreatitis and concurrent acute cholangitis should undergo ERCP within 24 h of admission | |||
|[[ACG guidelines classification scheme|Moderate]] | |||
|[[ACG guidelines classification scheme|Strong]] | |||
|- | |||
|ERCP is not needed in most patients with gallstone pancreatitis who lack laboratory or clinical evidence of ongoing biliary obstruction | |||
|[[ACG guidelines classification scheme|Low]] | |||
|[[ACG guidelines classification scheme|Strong]] | |||
|- | |||
|In the absence of cholangitis and/or jaundice, MRCP or endoscopic ultrasound (EUS) rather than diagnostic ERCP should be used to screen for choledocholithiasis if highly suspected | |||
|[[ACG guidelines classification scheme|Low]] | |||
|[[ACG guidelines classification scheme|Conditional]] | |||
|- | |||
|Pancreatic duct stents and/or postprocedure rectal nonsteroidal anti-inflammatory drug (NSAID) suppositories should be utilized to prevent severe post-ERCP pancreatitis in high-risk patients | |||
|[[ACG guidelines classification scheme|Moderate]] | |||
|[[ACG guidelines classification scheme|Conditional]] | |||
|} | |||
==References== | ==References== | ||
Revision as of 14:04, 25 October 2017
|
Acute pancreatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acute pancreatitis other imaging findings On the Web |
|
American Roentgen Ray Society Images of Acute pancreatitis other imaging findings |
|
Risk calculators and risk factors for Acute pancreatitis other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Other Imaging Findings
Role of ERCP
| Recommendation | Evidence Level | Strength of Recommendation |
|---|---|---|
| Patients with acute pancreatitis and concurrent acute cholangitis should undergo ERCP within 24 h of admission | Moderate | Strong |
| ERCP is not needed in most patients with gallstone pancreatitis who lack laboratory or clinical evidence of ongoing biliary obstruction | Low | Strong |
| In the absence of cholangitis and/or jaundice, MRCP or endoscopic ultrasound (EUS) rather than diagnostic ERCP should be used to screen for choledocholithiasis if highly suspected | Low | Conditional |
| Pancreatic duct stents and/or postprocedure rectal nonsteroidal anti-inflammatory drug (NSAID) suppositories should be utilized to prevent severe post-ERCP pancreatitis in high-risk patients | Moderate | Conditional |